首页> 外国专利> new pro and anticoagulant agent of sea cucumber (holothuria polii): purification and characterization.

new pro and anticoagulant agent of sea cucumber (holothuria polii): purification and characterization.

机译:海参(holothuria polii)的新的抗凝血剂:纯化和表征。

摘要

the present invention provides for a new sulfated glycosaminoglycan, on the basis of the tunics of sea cucumbers (holothuria polii) with anticoagulant activity of interest.the invention relates more particularly to the extraction, purification and structural characterization of a new anticoagulant agent, polysaccharide in nature.according to the method of the invention, the production of sulfated glycosaminoglycan is based on an enzymatic hydrolysis by papain and partially purified by a cationic detergent.the cetylpyridinium chloride (cpc), followed by fractionation, identification, characterization and evaluation of their biological activity.the purified glycosaminoglycan has been identified as a chondroitin sulfate (csfu fucosylated.the structural analysis by fourier transform infrared spectroscopy (ftir) and nuclear magnetic resonance (nmr) showed that the mono - and two-dimensional chemical structure of csfu is formed by disaccharidiques units consisting of glucuronic acid (aglu) ~ 1 / 3 of n-acetylgalactosamine (galnac) residues, most of which are variations in position c4 and c6 (galnac4,6s).these units are connected by disaccharidiques residues fucoses 2.4 - 3.4 - disulfate or disulfate.the percentage composition of the csfu reveals, in particular, a high content of sulphate (so4) groups 43.1 + 1% and a content of glucuronic acid to 22.5 + 1.9% with a 100 / carboxylate). in addition, the csfu is 60 + / - 5% of the crude polysaccharide fraction.the average molar mass number (mn) and weight (mw) of the polysaccharide were 35, 1 and 2.5 kda.in the present invention.the study of the anticoagulant activity of the purified csfu was highlighted by several specific tests of coagulation in either plasma or purified in the presence of hépatine systemcofactor ii (hcii) and antithrombin (at) in comparison with anticoagulant polysaccharides such as heparin and standard dermatan sulfate from the intestinal mucosa of swine.the csfu has remarkable anticoagulant activity mediated by physiological inhibitors of coagulation in the at and the hcii.it is extremely important to note that the csfu of sea cucumber (holothuria polii) has a pro and anticoagulant activity.according to the invention, the dual effect of coagulation is described for the first time in the native molecule.the csfu represents an alternative heparin like potential of marine origin and no adverse effects on platelet function.
机译:本发明基于具有目的抗凝活性的海参的外衣提供了一种新的硫酸化糖胺聚糖。本发明尤其涉及一种新的抗凝剂多糖的提取,纯化和结构表征。根据本发明的方法,硫酸化糖胺聚糖的生产是基于木瓜蛋白酶的酶促水解,并通过阳离子去污剂氯化十六烷基吡啶鎓(cpc)进行部分纯化,然后对其进行分级,鉴定,表征和评估其生物学性质。活性。纯化的糖胺聚糖被鉴定为硫酸软骨素(岩藻糖醇岩藻糖基化的。通过傅里叶变换红外光谱(ftir)和核磁共振(nmr)进行的结构分析表明,csfu的一维和二维化学结构是由葡萄糖醛酸(aglu)组成的双糖类单元〜 1 / 3个n-乙酰半乳糖胺(galnac)残基,大多数是c4和c6位(galnac4,6s)的变异,这些单元通过双糖残基岩藻油2.4-3.4-二硫酸盐或二硫酸盐连接。 csfu特别显示出高含量的硫酸根(so4)基团为43.1 + 1%,而葡萄糖醛酸含量为100%羧酸盐时为22.5 + 1.9%。另外,csfu为粗多糖级分的60±5%。在本发明中,多糖的平均摩尔质量数(mn)和重量(mw)为35、1和2.5kda。与血浆中抗凝多糖(如肝素和标准硫酸皮肤素)相比,在血浆中或在肝素系统辅因子ii(hcii)和抗凝血酶(at)存在下进行纯化的几种特定凝血试验中,突出显示了纯化csfu的抗凝活性。猪肠道粘膜中的csfu在at和hcii中由生理性凝血抑制剂介导,具有显着的抗凝血活性。非常重要的是要注意海参的csfu(holothuria polii)具有促凝血和抗凝血活性。发明人首次在天然分子中描述了凝血的双重作用。csfu代表了另一种肝素,如海洋来源的潜力,无不良作用血小板功能。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号